Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation

Duivenvoorden,Wilhelmina C.M.; Hopmans,Sarah N.; Gallino,Daniel; Farrell,Thomas; Gerdes,Carrie; Glennie,Diana; Lukka,Himu; Pinthus,Jehonathan H.

doi:10.3892/or.2015.4184

Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation

Authors:
- Wilhelmina C.M. Duivenvoorden
- Sarah N. Hopmans
- Daniel Gallino
- Thomas Farrell
- Carrie Gerdes
- Diana Glennie
- Himu Lukka
- Jehonathan H. Pinthus
View Affiliations

Affiliations: Department of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada, Department of Medical Physics, McMaster University, Hamilton, ON, Canada, Juravinski Cancer Centre, Hamilton, ON, Canada
Published online on: August 7, 2015 https://doi.org/10.3892/or.2015.4184
Pages: 1968-1976

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

While normal kidneys are relatively sensitive to ionizing radiation (IR), renal cell carcinoma (RCC) is considered radioresistant. Carbonic anhydrase IX (CA9), an enzyme that maintains intracellular pH by carbon dioxide dissolution, is upregulated in the majority of RCC, but not in normal kidneys. Since regulation of intracellular pH may enhance radiation effects, we hypothesized that inhibition of CA9 may radiosensitize RCC. Clonogenic survival assay of human clear cell RCC 786-O and murine RCC RAG cells in the presence of a pharmacological CA9 inhibitor or with shRNA-mediated knockdown of CA9 was performed to investigate the response to IR in vitro (single dose or fractionated) and in vivo. Extracellular pH changes were measured in vitro. Treatment with AEBS [4-(2-aminoethyl)benzene sulfonamide], a sulfonamide, was used as a pharmacological inhibitor of the enzymatic activity of CA9. Nude mice bearing subcutaneous xenografts of 786-O cells stably expressing CA9 shRNA or scrambled control were irradiated (6 Gy). Tumor growth was followed longitudinally in the 786-O-bearing mice receiving AEBS (50-200 µg/ml drinking water) or control (vehicle only) which were irradiated (6 Gy) and compared with mice receiving either IR or AEBS alone. In vitro inhibition of CA9 activity or expression significantly sensitized RCC cells to the effects of IR (p<0.05), an effect even more significant when hypofractionated IR was applied. In vivo irradiated xenografts from RCC cells transfected with CA9 shRNA were significantly smaller compared to irradiated xenografts from the scrambled shRNA controls (p<0.05). RCC xenografts from mice treated with AEBS in combination with IR grew significantly slower than all controls (p<0.05). Inhibition of CA9 expression or activity resulted in radiation sensitization of RCC in a preclinical mouse model.

View Figures

View References

1	Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG and Boldyreff B: Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol. 23:908–915. 2003. View Article : Google Scholar : PubMed/NCBI
2	Mountford PJ and Temperton DH: Recommendations of the International Commission on Radiological Protection (ICRP) 1990. Eur J Nucl Med. 19:77–79. 1992. View Article : Google Scholar : PubMed/NCBI
3	Nyhan MJ, El Mashad SM, O'Donovan TR, Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC and McKenna SL: VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin. Cell Oncol (Dordr). 34:225–234. 2011. View Article : Google Scholar
4	Grabmaier K, A de Weijert MC, Verhaegh GW, Schalken JA and Oosterwijk E: Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene. 23:5624–5631. 2004. View Article : Google Scholar : PubMed/NCBI
5	Rini BI and Small EJ: Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol. 23:1028–1043. 2005. View Article : Google Scholar
6	Swietach P, Hulikova A, Vaughan-Jones RD and Harris AL: New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene. 29:6509–6521. 2010. View Article : Google Scholar : PubMed/NCBI
7	Kleinmann N, Duivenvoorden WC, Hopmans SN, Beatty LK, Qiao S, Gallino D, Lhotak S, Daya D, Paschos A, Austin RC, et al: Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: Implications for progression. Clin Exp Metastasis. 31:169–183. 2014. View Article : Google Scholar
8	Akurathi V, Dubois L, Lieuwes NG, Chitneni SK, Cleynhens BJ, Vullo D, Supuran CT, Verbruggen AM, Lambin P and Bormans GM: Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia. Nucl Med Biol. 37:557–564. 2010. View Article : Google Scholar : PubMed/NCBI
9	Doyen J, Parks SK, Marcié S, Pouysségur J and Chiche J: Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis. Front Oncol. 2:1992012.
10	Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, et al: Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 158:905–919. 2001. View Article : Google Scholar : PubMed/NCBI
11	Neuman MG, Shear NH, Malkiewicz IM, Taeri M, Shapiro LE, Krivoy N, Haber J, Gomez M, Fish J, Cartotto R, et al: Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides. Transl Res. 149:243–253. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kim TH, Somerville PJ and Freeman CR: Unilateral radiation nephropathy - the long-term significance. Int J Radiat Oncol Biol Phys. 10:2053–2059. 1984. View Article : Google Scholar : PubMed/NCBI
13	Kjaer M, Frederiksen PL and Engelholm SA: Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys. 13:665–672. 1987. View Article : Google Scholar : PubMed/NCBI
14	Kao GD, Malkowicz SB, Whittington R, D'Amico AV and Wein AJ: Locally advanced renal cell carcinoma: Low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Radiology. 193:725–730. 1994. View Article : Google Scholar : PubMed/NCBI
15	Svedman C, Karlsson K, Rutkowska E, Sandström P, Blomgren H, Lax I and Wersäll P: Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol. 47:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
16	Hensley HH, Hannoun-Levi JM, Hachem P, Mu Z, Stoyanova R, Khor LY, Agrawal S and Pollack A: PKA knockdown enhances cell killing in response to radiation and androgen deprivation. Int J Cancer. 128:962–973. 2011. View Article : Google Scholar
17	Barazzuol L, Jena R, Burnet NG, Jeynes JC, Merchant MJ, Kirkby KJ and Kirkby NF: In vitro evaluation of combined temozolomide and radiotherapy using X rays and high-linear energy transfer radiation for glioblastoma. Radiat Res. 177:651–662. 2012. View Article : Google Scholar : PubMed/NCBI
18	McIntyre A, Patiar S, Wigfield S, Li JL, Ledaki I, Turley H, Leek R, Snell C, Gatter K, Sly WS, et al: Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. Clin Cancer Res. 18:3100–3111. 2012. View Article : Google Scholar : PubMed/NCBI
19	Cianchi F, Vinci MC, Supuran CT, Peruzzi B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini A, et al: Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells. J Pharmacol Exp Ther. 334:710–719. 2010. View Article : Google Scholar : PubMed/NCBI
20	Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogné JM, et al: Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol. 99:424–431. 2011. View Article : Google Scholar : PubMed/NCBI
21	Fuks Z and Kolesnick R: Engaging the vascular component of the tumor response. Cancer Cell. 8:89–91. 2005. View Article : Google Scholar : PubMed/NCBI
22	De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, et al: Radiotherapy for renal-cell carcinoma. Lancet Oncol. 15:e170–e177. 2014. View Article : Google Scholar : PubMed/NCBI